2014
DOI: 10.1021/pr5002737
|View full text |Cite
|
Sign up to set email alerts
|

Using an in Situ Proximity Ligation Assay to Systematically Profile Endogenous Protein–Protein Interactions in a Pathway Network

Abstract: Signal transduction pathways in the cell require protein-protein interactions (PPIs) to respond to environmental cues. Diverse experimental techniques for detecting PPIs have been developed. However, the huge amount of PPI data accumulated from various sources poses a challenge with respect to data reliability. Herein, we collected ∼ 700 primary antibodies and employed a highly sensitive and specific technique, an in situ proximity ligation assay, to investigate 1204 endogenous PPIs in HeLa cells, and 557 PPIs… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(14 citation statements)
references
References 50 publications
(79 reference statements)
0
14
0
Order By: Relevance
“…We evaluated the APP and BACE1 inhibitory activities, which inhibit Ab aggregation; in addition, the matrix clearance properties of MMP-2 and MMP-9 implicated FA was actively involved in the alteration of matrix proteins and that it played a major role in in vitro extracellular matrix remodeling. As shown in a previous in situ proximity ligation assay ( in situ PLA), which is a new technique to monitor PPI with high specificity and sensitivity, it was found that APP, MMP2 and MMP9 all interacted with TGFB1, and the interaction of MMP2 and BACE1 was also positive (Chen et al, 2014 ). Furthermore, from the Human Protein Reference Database (HPRD) in the STRING platform (Higashi and Miyazaki, 2003 ), the COOH-terminal parts of APP were found to interact with the extracellular matrix and highly selectively inhibit MMP2, in which the decapeptide region of APP was likely an active site-directed inhibitor toward MMP2.…”
Section: Discussionmentioning
confidence: 86%
“…We evaluated the APP and BACE1 inhibitory activities, which inhibit Ab aggregation; in addition, the matrix clearance properties of MMP-2 and MMP-9 implicated FA was actively involved in the alteration of matrix proteins and that it played a major role in in vitro extracellular matrix remodeling. As shown in a previous in situ proximity ligation assay ( in situ PLA), which is a new technique to monitor PPI with high specificity and sensitivity, it was found that APP, MMP2 and MMP9 all interacted with TGFB1, and the interaction of MMP2 and BACE1 was also positive (Chen et al, 2014 ). Furthermore, from the Human Protein Reference Database (HPRD) in the STRING platform (Higashi and Miyazaki, 2003 ), the COOH-terminal parts of APP were found to interact with the extracellular matrix and highly selectively inhibit MMP2, in which the decapeptide region of APP was likely an active site-directed inhibitor toward MMP2.…”
Section: Discussionmentioning
confidence: 86%
“…Ets-1 was found to bind to Smad3 in HeLa cells 28 . In primary hepatocytes, immunofluorescence experiments were performed to show a co-localization of Ets-1 and Smad3 in the nucleus (Fig.…”
Section: Resultsmentioning
confidence: 95%
“…The differential topological structures obtained through the use of different GO weighting approaches suggest that ANLN and KDR interact and create synergies in BPs and MFs, but do not share the use or functionalities of CCs. PDGFRB encodes a typical receptor tyrosine kinase, PDGFRβ, which physically interacts with PTEN according to an in situ proximity ligation assay (55). PTEN is a representative molecule in PI3K/PTEN signaling that shares the same biological pathway with ANLN (7).…”
Section: Discussionmentioning
confidence: 99%